Navire Pharma
Biotech · Private
Small molecule inhibitors targeting SHP2 and RAS pathway proteins for RAS/MAPK-driven solid tumors
navirepharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 4 granted · 11 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2976 | CAMBIUM ONCOLOGY LLC | — | — |
| 2977 | MEDICATIONS DISCOVERY TEXAS, INC. | — | — |
| 2978 | BOLDEN THERAPEUTICS, INC. | — | — |
| 2979 | Navire Pharma | — | — |
| 2980 | POW GENETIC SOLUTIONS, INC. | — | — |
| 2981 | QUORUM INNOVATIONS, LLC | — | — |
| 2982 | NuPeak Therapeutics, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Combination Therapy Using A Substituted PYRIMIDIN-4(3H)-ONE And Nivolumab As Well As Its Use In The Treatment Of Cancerapplication
- Substituted PYRIMIDIN-4(3H)-ONES For Use In Treating Cancerapplication
- PTPN11 Inhibitorsgranted
- Substituted Heterocyclic Inhibitors Of PTPN11granted
- PTPN11 Inhibitorsgranted
- Substituted Heterocyclic Inhibitors Of PTPN11granted
- Treatment Methods With Substituted PYRIMIDIN-4(3H)-ONESapplication
- Treatment Methods With Substituted PYRIMIDIN-4(3H)-ONESapplication
- PTPN11 Inhibitorsapplication
- Combination Therapy Using A Pyrimidone Derivative As PTPN11 Inhibitor And A PD-1/PD-L1 Inhibitor And Its Use In The Treatment Of Cancerapplication
- PTPN11 Inhibitorsapplication
- Treatment Methods With Substituted PYRIMIDIN-4(3H)-ONESapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.